Showing 1 - 14 results of 14 for search 'Jessica M Conway', query time: 0.07s Refine Results
  1. 1
    A hepatitis C virus infection model with time-varying drug effectiveness: solution and analysis.

    A hepatitis C virus infection model with time-varying drug effectiveness: solution and analysis. by Jessica M Conway, Alan S Perelson

    Published 2014-08-01
    Get full text
    Article
  2. 2
    A stochastic model of latently infected cell reactivation and viral blip generation in treated HIV patients.

    A stochastic model of latently infected cell reactivation and viral blip generation in treated HIV patients. by Jessica M Conway, Daniel Coombs

    Published 2011-04-01
    Get full text
    Article
  3. 3
    Residual Viremia in Treated HIV+ Individuals.

    Residual Viremia in Treated HIV+ Individuals. by Jessica M Conway, Alan S Perelson

    Published 2016-01-01
    Get full text
    Article
  4. 4
    Incorporating Intracellular Processes in Virus Dynamics Models

    Incorporating Intracellular Processes in Virus Dynamics Models by Stanca M. Ciupe, Jessica M. Conway

    Published 2024-04-01
    Get full text
    Article
  5. 5
    Mathematical Modeling of Remdesivir to Treat COVID-19: Can Dosing Be Optimized?

    Mathematical Modeling of Remdesivir to Treat COVID-19: Can Dosing Be Optimized? by Jessica M. Conway, Pia Abel zur Wiesch

    Published 2021-07-01
    Get full text
    Article
  6. 6
    Predictions of time to HIV viral rebound following ART suspension that incorporate personal biomarkers.

    Predictions of time to HIV viral rebound following ART suspension that incorporate personal biomarkers. by Jessica M Conway, Alan S Perelson, Jonathan Z Li

    Published 2019-07-01
    Get full text
    Article
  7. 7
    Modeling dynamics of acute HIV infection incorporating density-dependent cell death and multiplicity of infection.

    Modeling dynamics of acute HIV infection incorporating density-dependent cell death and multiplicity of infection. by Ellie Mainou, Ruy M Ribeiro, Jessica M Conway

    Published 2024-06-01
    Get full text
    Article
  8. 8
    Impact of different oseltamivir regimens on treating influenza A virus infection and resistance emergence: insights from a modelling study.

    Impact of different oseltamivir regimens on treating influenza A virus infection and resistance emergence: insights from a modelling study. by Laetitia Canini, Jessica M Conway, Alan S Perelson, Fabrice Carrat

    Published 2014-04-01
    Get full text
    Article
  9. 9
    On the duration of the period between exposure to HIV and detectable infection

    On the duration of the period between exposure to HIV and detectable infection by Bernhard P. Konrad, Darlene Taylor, Jessica M. Conway, Gina S. Ogilvie, Daniel Coombs

    Published 2017-09-01
    Get full text
    Article
  10. 10
    Recombination Enhances HIV-1 Envelope Diversity by Facilitating the Survival of Latent Genomic Fragments in the Plasma Virus Population.

    Recombination Enhances HIV-1 Envelope Diversity by Facilitating the Survival of Latent Genomic Fragments in the Plasma Virus Population. by Taina T Immonen, Jessica M Conway, Ethan O Romero-Severson, Alan S Perelson, Thomas Leitner

    Published 2015-12-01
    Get full text
    Article
  11. 11
    Models of SIV rebound after treatment interruption that involve multiple reactivation events.

    Models of SIV rebound after treatment interruption that involve multiple reactivation events. by Christiaan H van Dorp, Jessica M Conway, Dan H Barouch, James B Whitney, Alan S Perelson

    Published 2020-10-01
    Get full text
    Article
  12. 12
    A New Age-Structured Multiscale Model of the Hepatitis C Virus Life-Cycle During Infection and Therapy With Direct-Acting Antiviral Agents

    A New Age-Structured Multiscale Model of the Hepatitis C Virus Life-Cycle During Infection and Therapy With Direct-Acting Antiviral Agents by Barbara de M. Quintela, Jessica M. Conway, James M. Hyman, Jeremie Guedj, Rodrigo W. dos Santos, Marcelo Lobosco, Alan S. Perelson

    Published 2018-04-01
    Get full text
    Article
  13. 13
    Understanding early HIV-1 rebound dynamics following antiretroviral therapy interruption: The importance of effector cell expansion.

    Understanding early HIV-1 rebound dynamics following antiretroviral therapy interruption: The importance of effector cell expansion. by Tin Phan, Jessica M Conway, Nicole Pagane, Jasmine Kreig, Narmada Sambaturu, Sarafa Iyaniwura, Jonathan Z Li, Ruy M Ribeiro, Ruian Ke, Alan S Perelson

    Published 2024-07-01
    Get full text
    Article
  14. 14
    Assessing the impact of autologous virus neutralizing antibodies on viral rebound time in postnatally SHIV-infected ART-treated infant rhesus macaques

    Assessing the impact of autologous virus neutralizing antibodies on viral rebound time in postnatally SHIV-infected ART-treated infant rhesus macaques by Ellie Mainou, Stella J. Berendam, Veronica Obregon-Perko, Emilie A. Uffman, Caroline T. Phan, George M. Shaw, Katharine J. Bar, Mithra R. Kumar, Emily J. Fray, Janet M. Siliciano, Robert F. Siliciano, Guido Silvestri, Sallie R. Permar, Genevieve G. Fouda, Janice McCarthy, Ann Chahroudi, Jessica M. Conway, Cliburn Chan

    Published 2024-09-01
    Get full text
    Article

Search Tools: